Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

ConditionCommunity-acquired Pneumonia

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18+

SponsorMayo Clinic

About this trial

The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.

Eligibility criteria

Qualifiers

None

Disqualifiers

High clinical suspicion for Legionella pneumonia

Allergy or contraindication to the use of either azithromycin or doxycycline (usual clinical practice)

Antibiotics not for CAP

Pregnant women (based on clinical assessment as part of standard of care)

Trial design

Treatments tested in this trial

Doxycycline
Azithromycin

Treatment groups

1,120 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov